Drugs / Bosinji
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03386149 | Dec 2017 → Dec 2019 | lumbar disk disease | Kyunghee University Medical Center | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bosinji | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03386149 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The effectiveness of Bosinji, one of the herbal medicines used for low back pain and radiating pain in patient with LHIVD” PMID 30558079 ↗ Dec 2018 |
| Route | Oral | “2.5g of Bosinji granule (Tsumura \& Co., Tokyo, Japan) will be orally administered” NCT03386149 ↗ |